|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The calcium sensing receptor(CaR) is involved in strontium ranelate-induced osteoblast proliferation显示文摘 | Naibedya C Stephen JQ Olga K | 2007 | Bioche Pharmacol2007，74，3： | 1 |
| 2 | Expression of Extracellular Calcium (Ca 2+ o )-Sensing Receptor in Human Peripheral Blood Monocytes显示文摘 | Toru Yamaguchi Ivona Olozak Naibedya Chattopadhyay Robert R. Butters Olga Kifor David T. Scadden Edward M. Brown | 1998 | Biochemical and Biophysical Research Communications1998，，2： | 1 |
| 3 | The emerging role of pituitary tumortransforming gene in tumorigenesis 显示文摘 | Jacob T Deepthi K Naibedya C | 2006 | Clin Med Res2006，4，2： | 1 |
| 4 | The emerging role of pituitary tumortransforming gene in tumorigenesis显示文摘 | Jacob T Deepthi K Naibedya C | 2006 | Clin Med Res2006，4，2： | 1 |
| 5 | The emerging role of pituitary tumor transforming gene in tumorigenesis显示文摘 | Jacob T Deepthi K Naibedya C | 2006 | Clin Med Res2006，4，2： | 1 |
| 6 | The calcium sensing receptor (CaR) is involved in strontium ranelate - induced osteoblast proliferation 显示文摘 | Naibedya C Stephen JQ Olga K | 2007 | Bioche phannacol2007，74，： | 1 |
| 7 | The calciumsensing receptor (CAR) is involved in strontium ranelate-induced osteoblast proliferation 显示文摘 | Naibedya C Stephen JQ Olga K | 2007 | Bioche pharmacol2007，74，： | 1 |
| 8 | The calcium sensing receptor (CAR) is involved in strontium ranelate-induced osteoblast prolifera- tion显示文摘 | Naibedya C Stephen JQ Olga K | 2007 | Bioche Phannaeol2007，74，3： | 1 |
| 9 | The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation显示文摘 | Naibedya Chattopadhyay Stephen J. Quinn Olga Kifor Chianping Ye Edward M. Brown | 2007 | Biochemical Pharmacology2007，，3： | 1 |
| 10 | The calciumming receptoris in- volved in strontium rane ] ate induced osteoblast proliferation 显示文摘 | Naibedya C Stephen JQ Olga K | 2007 | Bioche phar- maeol2007，74，： | 1 |
| 11 | A Comprehensive Review on Preclinical Safety and Toxicity of Medicinal Plants显示文摘Background:Globally,80%people use plant-derived products for treating or preventing diseases.One prevalent perception about medicinal plants is that they are safe and devoid of adverse effects.However,approximately 1,50,000 plants contain toxic substances.Objective:The present review focuses on medicinal plant extracts/fractions toxicity assessments made in preclin-ical models by oral route.Methods:Detail studies were searched from databases including PubMed and Google Scholar.A manual reference screening of the selected studies was done to identify relevant articles,with no language restriction being imposed at the time of searching.Results:The studies included were performed in rodents,and the test substances were administered orally.Our search revealed 33 widely used plants or products with significant toxicity,and phytochemicals from these plants have been summarized.Through a systematic review,we identified a plethora of medicinal plant extracts reporting safety and toxicity concerns.Conclusion:In the future,preclinical toxicokinetic studies of herbs and the determination of their no-observed-adverse-effect levels are required for a complete safety assessment.Finally,the interaction of herbs with com-monly used/over-the-counter drugs in terms of the latter’s metabolic profile should be undertaken. | Madhav Nilakanth Mugale Kapil Dev Bhumika S.More Vaishali Sunil Mishra Kaveri R.Washimkar Kishan Singh Rakesh Maurya Srikanta Kumar Rath Debprasad Chattopadhyay Naibedya Chattopadhyay | 2024 | Clinical Complementary Medicine and Pharmacology2024，4，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员